Unmasking Diabetic Kidney Disease: A Journey Beyond the Basics agendocrine.wordpress.com/2023/06/18/unm…

An In-depth Examination of Semaglutide: Uses and Precautions agendocrine.wordpress.com/2023/06/29/an-…

Retratrutide: A Potential Game-Changer in Obesity Treatment agendocrine.wordpress.com/2023/06/30/ret…

The Future of Weight Management: A Closer Look at Orforglipron agendocrine.wordpress.com/2023/07/01/the…

Everything You Need to Know About Familial Hypercholesterolemia agendocrine.wordpress.com/2023/07/08/eve…

Managing Your Diabetes while Embracing the Beach: A Comprehensive Guide agendocrine.wordpress.com/2023/07/09/man…

Kicking it at a Major League Soccer Game with Diabetes: Your Essential Playbook agendocrine.wordpress.com/2023/07/15/kic…

Breaking Down Hypoglycemia: A Simple Guide to Diagnosis and Testing agendocrine.wordpress.com/2023/07/24/bre…

Comprehensive Guide to Vaccinations for Individuals Living with Diabetes agendocrine.wordpress.com/2023/07/25/com…

A Deep Dive into Adrenal Health: Understanding Adrenal Fatigue and Recognized Adrenal Disorders agendocrine.wordpress.com/2023/07/26/a-d…

The Dangers of the Medical "Hot Take": Unraveling the Metformin and Statins Narrative agendocrine.wordpress.com/2023/07/30/the…

Navigating Emotional Stressors with Diabetes: A Holistic Approach agendocrine.wordpress.com/2023/08/06/nav…

Wegovy/semaglutide cardiovascular should generate a fundamental shift from insurers regarding the treatment of Cardiometabolic disease. I suspect the shift will rocky. #select

Embracing Autumn: A Seasonal Guide for People with Diabetes agendocrine.wordpress.com/2023/10/09/emb…

Breaking News in Diabetes Care: The FLOW Trial and The Rising Star of GLP-1 Agonists agendocrine.wordpress.com/2023/10/12/bre…

Semaglutide Shakes Up Cardio Health: The SELECT Trial agendocrine.wordpress.com/2023/11/13/sem…

Demystifying Drug Costs: A Guide for Patients agendocrine.wordpress.com/2024/03/19/dem…

Catalyst trial changing the face of diabetes #NoxiousNine

🚨 PRESS RELEASE: One in four patients with difficult-to-control T2D have high cortisol levels, according to the CATALYST study. Learn more about this groundbreaking research presented at #ADASciSessions & its implications for diabetes management here: 🔗 diabetes.org/newsroom/press…

At #ADASciSessions Dr. DeFronzo underscores the role of hypercortisolism in difficult-to-control type 2 diabetes by suggesting it may be time to revise his famous "Ominous Octet" with the "Noxious Nine". Hear more from Dr. DeFronzo: hcplive.com/view/catalyst-… #T2D #Diabetes